Pharmaceutical GMP and Regulatory Affairs in Southeast Asia
Date: 29 June 2021
Speaker: Kenny Peng
Executive VP, Asia, PharmEng Technology, Singapore
Executive VP, Asia, PharmEng Technology, Singapore
Content:
Current regulatory developments, insights in overcoming regulatory barriers, and its impact on research and development for medicinal and medical products in major Southeast Asian markets (e.g. Singapore, Malaysia, Indonesia, Philippines, Thailand, Vietnam) in comparison to more mature East Asian countries, including pre-clinical, clinical, manufacturing, and dossier requirements, will be discussed.
Besides regulatory assessments, market access analysis while anticipating competitive scenarios is necessary in driving successful new product developments and optimizing commercial potential; trade barriers, differences between local and imported products, competing products, reimbursement practices, healthcare policies and other realistic barriers to market access will be explored.
Besides regulatory assessments, market access analysis while anticipating competitive scenarios is necessary in driving successful new product developments and optimizing commercial potential; trade barriers, differences between local and imported products, competing products, reimbursement practices, healthcare policies and other realistic barriers to market access will be explored.
Panel Discussion: How to build a win-win partnership in pharma industry between China and India
Date: 22 June 2021
Speaker: Rosy TU, Renzong ZHU, Steven YU, Sumit Kumar
Rosy TU from CCCMHPIE;
Renzong ZHU from CCCMHPIE;
Steven YU from China Chinopharma;
Sumit Kumar from Dr. Reddy’s Laboratories
Rosy TU from CCCMHPIE;
Renzong ZHU from CCCMHPIE;
Steven YU from China Chinopharma;
Sumit Kumar from Dr. Reddy’s Laboratories
Indian Pharmaceuticals Impacting Global Health and Opportunities to Collaborate with Chinese Pharma
Date: 22 June 2021
Speaker: Mr. Sumit Kumar, Mr. Yuan CAO
Mr. Sumit Kumar | VP & Region Head API Marketing and Sales, Dr. Reddy's Laboratories
Mr. Yuan CAO | Sales Director, Dr. Reddy’s Laboratories
Mr. Sumit Kumar | VP & Region Head API Marketing and Sales, Dr. Reddy's Laboratories
Mr. Yuan CAO | Sales Director, Dr. Reddy’s Laboratories
Content:
Here's the agenda for this webinar:
- The role of API and generics development and manufacturing in India
- How this creates value for the Chinese market
- The role of API and generics development and manufacturing in India
- How this creates value for the Chinese market
Requirements and Practices of Imported Drug Registration in China
Date: 22 June 2021
Speaker: Steven YU
International Business Director, China Chinopharma Limited
International Business Director, China Chinopharma Limited
Content:
Here's the agenda for this webinar:
- API market comparison between India and China
- Strategies to better enter the Chinese market
- Drug registration requirements and procedures in China
- Process and contents of on-site audit
- API market comparison between India and China
- Strategies to better enter the Chinese market
- Drug registration requirements and procedures in China
- Process and contents of on-site audit
Development Trend of China’s API Industry and Cooperation Prospect with India
Date: 22 June 2021
Speaker: Renzong ZHU
Deputy Secretary of Sub-chamber from China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)
Deputy Secretary of Sub-chamber from China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)
Content:
- Overview of China’s API industry development and its position in the global market
- China’s current API import & export situation
- Analysis and prospect of cooperation between India and China on API industry
- Overview of China’s API industry development and its position in the global market
- China’s current API import & export situation
- Analysis and prospect of cooperation between India and China on API industry
Play
Pharma Sources Insight January 2025
